v3.25.2
INVESTMENTS (Details Narrative) - USD ($)
9 Months Ended 12 Months Ended
Nov. 01, 2024
Oct. 17, 2024
Nov. 29, 2018
Jun. 11, 2018
Jun. 30, 2025
Sep. 30, 2024
Defined Benefit Plan Disclosure [Line Items]            
Common shares 15,426,385 15,426,385        
Zander Therapeutics Inc [Member]            
Defined Benefit Plan Disclosure [Line Items]            
Fair value investment entities         7.90%  
Common shares       470,588 470,588 470,588
Preferred stock shares     725,000   725,000 725,000
Prepaid rent and accrued interest     $ 13,124